Investing.com -- Glanbia plc (LON:GL9), the Better Nutrition company, said on Wednesday that it will commence a share buy-back programme of up to €50 million, which sent the company's shares higher. At 4:35 am (0835 GMT), Glanbia plc was trading 3.8% higher at €17.58. This is set to commence today and will run through to December 19th, unless extended or modified, the company said in a statement. The programme aims to reduce the number of outstanding shares and is in line with the €50 million share buy-back authority approved earlier this year. Glanbia has appointed J&E Davy to manage the buy-back, which will proceed independently of the company’s direct influence. Under the terms of the agreement, Davy will execute the buy-backs within predefined parameters, ensuring compliance with the Market Abuse Regulation and relevant rules. The share buy-back follows a previous similar initiative completed between May 1st and June 26th, which repurchased a portion of the company's shares. Related Articles Glanbia stock up on new share buy back plan Apple supplier Foxconn's profit beats forecasts as it rides AI boom Straumann stock rallies on upbeat results
Glanbia stock up on new share buy back plan
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...